CORNEA

metrics 2024

Exploring the frontiers of corneal research and innovation.

Introduction

CORNEA is a prestigious peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the rapidly advancing field of ophthalmology with a particular emphasis on corneal research and diseases. With an impact factor categorized in the prestigious Q1 quartile for its discipline, CORNEA has established itself as a leading platform for the dissemination of both fundamental and clinical studies since its inception in 1982. The journal is ranked 25th out of 137 in the Scopus Medicine-Ophthalmology category, placing it in the 82nd percentile among its peers, which underscores its vital role in influencing ocular research and clinical practices. While the journal is not currently open access, it provides valuable insights and updates for professionals, researchers, and students working to advance knowledge in corneal health, contributing significantly to the ongoing dialogue in the ophthalmological community. With a commitment to excellence, CORNEA continues to publish high-quality research and reviews in its pursuit to improve ocular outcomes and patient care.

Metrics 2024

SCIMAGO Journal Rank1.02
Journal Impact Factor1.90
Journal Impact Factor (5 years)2.30
H-Index138
Journal IF Without Self1.90
Eigen Factor0.01
Normal Eigen Factor1.55
Influence0.59
Immediacy Index0.70
Cited Half Life9.60
Citing Half Life8.80
JCI1.09
Total Documents7161
WOS Total Citations11823
SCIMAGO Total Citations46035
SCIMAGO SELF Citations6334
Scopus Journal Rank1.02
Cites / Document (2 Years)2.07
Cites / Document (3 Years)2.42
Cites / Document (4 Years)2.47

Metrics History

Rank 2024

Scopus

Ophthalmology in Medicine
Rank #25/137
Percentile 81.75
Quartile Q1

IF (Web Of Science)

OPHTHALMOLOGY
Rank 44/95
Percentile 54.20
Quartile Q2

JCI (Web Of Science)

OPHTHALMOLOGY
Rank 24/95
Percentile 74.74
Quartile Q2

Quartile History

Similar Journals

Middle East African Journal of Ophthalmology

Fostering collaboration for a brighter vision.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0974-9233Frequency: 4 issues/year

The Middle East African Journal of Ophthalmology is a distinguished publication dedicated to advancing knowledge in the field of ophthalmology, published by Wolters Kluwer Medknow Publications in India. With a robust focus on contributions that bridge the gap between clinical practices and scientific research, this journal serves as a crucial platform for researchers, practitioners, and students alike. Since its inception, it has consistently disseminated high-impact research, achieving notable recognition with a Q3 ranking in both Medicine (miscellaneous) and Ophthalmology categories as of 2023. Despite being a newer entrant into the scholarly landscape, it features an array of innovative articles, highlighting significant advancements and emerging trends in ocular health. Researchers may access a wealth of knowledge through its open access articles, promoting the dissemination of vital ophthalmic research that is relevant in both Middle Eastern and African contexts. By fostering collaboration and communication among professionals in the field, the Middle East African Journal of Ophthalmology is committed to championing excellence in eye care and elevating the standard of research applicable to global populations.

SURVEY OF OPHTHALMOLOGY

Exploring Innovations in Vision Health
Publisher: ELSEVIER SCIENCE INCISSN: 0039-6257Frequency: 6 issues/year

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

Ocular Surface

Advancing the Frontiers of Ocular Research
Publisher: ELSEVIERISSN: 1542-0124Frequency: 4 issues/year

Ocular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.

CURRENT EYE RESEARCH

Pioneering Research for a Brighter Vision
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Eye & Contact Lens-Science and Clinical Practice

Advancing ocular health through innovative research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1542-2321Frequency: 6 issues/year

Eye & Contact Lens-Science and Clinical Practice, published by Lippincott Williams & Wilkins, stands as a premier journal in the fields of ophthalmology and contact lens research. With an ISSN of 1542-2321 and an E-ISSN of 1542-233X, this journal serves as a vital resource for researchers, clinicians, and students dedicated to the study and application of eye care practices. Maintaining a distinguished impact factor within the Q2 category of Medicine and Ophthalmology as of 2023, it ranks impressively at #33 among 137 journals, placing it in the top 76th percentile according to Scopus metrics. Since its inception in 1986, Eye & Contact Lens has consistently delivered cutting-edge research and clinical insights, facilitating advancements in therapeutic techniques for contact lens wear and ocular health. Though not an Open Access journal, it remains accessible through institutional subscriptions, ensuring that essential findings are shared among professionals in the field. The objective of the journal is to present high-quality, peer-reviewed articles that advance the science and practice of eye care, making it an indispensable tool for those seeking to enhance their knowledge and contribute to this dynamic discipline.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Pioneering Research for Better Vision
Publisher: SPRINGERISSN: 0721-832XFrequency: 12 issues/year

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

JOURNAL OF CATARACT AND REFRACTIVE SURGERY

Innovating techniques for optimal patient outcomes.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0886-3350Frequency: 12 issues/year

The Journal of Cataract and Refractive Surgery, published by Lippincott Williams & Wilkins, stands as a cornerstone in the field of ophthalmology, documenting groundbreaking research and advancements in cataract and refractive surgical techniques since its inception in 1986. With an impressive Q1 ranking across key categories such as Ophthalmology, Sensory Systems, and Surgery, this journal plays a vital role in disseminating high-impact findings that shape clinical practices and enhance patient outcomes. Its rigorous peer-review process ensures the publication of only the most relevant and innovative studies, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing the field of eye care. Although not an open-access publication, the journal's commitment to excellence is reflected in its robust citation metrics and significant standing in various Scopus rankings; it ranks 63rd in Surgery and 23rd in Ophthalmology, underscoring its influence and prestige in the medical community. For those invested in the evolving landscape of eye surgery, the Journal of Cataract and Refractive Surgery remains a pivotal source of knowledge and forward-thinking perspectives.

Taiwan Journal of Ophthalmology

Empowering researchers to enhance vision care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2211-5056Frequency: 4 issues/year

Taiwan Journal of Ophthalmology is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal has been a vital resource for researchers, practitioners, and students since its inception in 2012. With an ISSN of 2211-5056 and an E-ISSN of 2211-5072, it provides a platform for sharing innovative research, clinical findings, and reviews pertinent to eye health and vision science. The journal is indexed in Scopus and currently holds a Q3 quartile ranking within the ophthalmology category, reflecting its commitment to quality and relevance in the medical community. Located in Mumbai, India, Taiwans Journal of Ophthalmology aims to foster discussions and disseminate knowledge that promotes better understanding and treatment of ocular diseases, ensuring that the latest advancements reach a global audience. By embracing open-access policies, the journal underscores its dedication to making valuable insights readily available to all interested parties, thus contributing significantly to the discourse in ophthalmic research.

Open Ophthalmology Journal

Illuminating the path to better vision through research.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1874-3641Frequency: 1 issue/year

The Open Ophthalmology Journal, published by Bentham Science Publishers Ltd, is a vital resource in the field of ophthalmology, dedicated to advancing knowledge through open-access research. With an ISSN of 1874-3641, it offers a platform for the dissemination of innovative studies from 2011 to 2024, focusing on the latest developments in eye care and vision science. Despite being categorized in the lower quartile (Q4) according to the 2023 rankings, and holding a position in the Scopus Ricks at 113 out of 137 in the ophthalmology domain, the journal serves as a valuable outlet for emerging scholars and seasoned researchers alike to share their findings. The journal's commitment to accessibility ensures that its content is available to a broad audience, promoting collaboration and knowledge exchange. Located in the Netherlands, The Open Ophthalmology Journal aspires to become a cornerstone for those passionate about understanding and improving ocular health through rigorous scientific inquiry.

Spektrum der Augenheilkunde

Navigating the Spectrum of Eye Health
Publisher: SPRINGER WIENISSN: 0930-4282Frequency: 6 issues/year

Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.